News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 340
- Sources here
- 17
- Companies here
- 21
Search results
Stored financial headlines
Active search
340 matching headlines
Ticker or company: SANAMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Sanara MedTech (SMTI) Stock Stays Quiet As Profitability Meets Debt Scrutiny
Sanara MedTech (SMTI) recently turned profitable in Q2 2026, reporting net income of US$0.40m from continuing operations, a significant improvement from a loss in the prior year. Despite this positive shift and increased revenue, the stock's reaction was muted, with concerns remaining over thin …
SMTI
main company
Sharemaestro market context
Trend signal active
52 weeks +0.6% · Next-week setup negative 41.2%
USANA Health Sciences (USNA) sees Renaissance report 5.19% equity stake
Renaissance Technologies LLC and Renaissance Technologies Holdings Corporation have disclosed a 5.19% equity stake in USANA Health Sciences Inc. As of June 30, 2026, these entities beneficially own 958,520 shares of USANA common stock, exercising sole voting and dispositive power. The filing, an amended …
USNA
main company
Sharemaestro market context
Price below Trend Line
52 weeks -58.5%
HC Wainwright Has Pessimistic Outlook of SANA Q3 Earnings
HC Wainwright has lowered its Q3 2026 earnings forecast for Sana Biotechnology (NASDAQ:SANA) to a loss of $0.14 per share, anticipating continued losses through future fiscal years. Despite this, Sana's last quarterly loss of $0.13 per share exceeded analyst expectations. The stock currently holds …
SANA
main company
Sharemaestro market context
Price above Trend Line
52 weeks -0.8%
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)
Sanara MedTech Inc. announced its financial results for the second quarter and first six months of 2026, reporting increased net revenue and gross profit. The company's net revenue rose 9% to $28.1 million in Q2 2026 and 14% to $55.9 million for the first …
SMTI
main company
Sharemaestro market context
Trend signal active
52 weeks +0.6% · Next-week setup negative 41.2%
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates
Sanara MedTech Inc. (SMTI) reported Q2 earnings of $0.05 per share, significantly beating the Zacks Consensus Estimate of $0.02, representing a 150% surprise. Despite missing revenue estimates at $28.14 million, the company's shares have gained 46.7% year-to-date. SMTI currently holds a Zacks Rank #3 …
SMTI
main company
Sharemaestro market context
Trend signal active
52 weeks +0.6% · Next-week setup negative 41.2%
Sanara MedTech (SMTI) grows H1 2026 revenue to $55.9M and trims loss
Sanara MedTech Inc. (SMTI) reported significant revenue growth for the first half of 2026, reaching $55.9 million, primarily driven by strong sales of its soft tissue repair products. The company also substantially reduced its net loss attributable to shareholders, nearly breaking even with a …
SMTI
main company
Sharemaestro market context
Trend signal active
52 weeks +0.6% · Next-week setup negative 41.2%
Sanara MedTech Inc. Q2 2026: Revenue $28.14M, EPS $(0.05) — 10-Q Summary
Sanara MedTech Inc. reported its Q2 2026 financial results, with revenue reaching $28.14M, a 9.1% increase year-over-year. The company posted a diluted loss per share of $(0.05), an improvement from $(0.23) in Q2 2025. This growth was primarily driven by surgical soft tissue repair …
SMTI
main company
Sharemaestro market context
Trend signal active
52 weeks +0.6% · Next-week setup negative 41.2%
Sanara MedTech Inc. (SMTI) Releases Q2 2026 Earnings: Revenue Rises 8.9%
Sanara MedTech Inc. (SMTI) reported an 8.9% increase in revenue for Q2 2026, reaching $28.1 million, with gross profit rising to $26.2 million. Despite strong top-line growth, the company posted a net loss of $(0.05) per diluted share. The article also details hedge fund …
SMTI
main company
Sharemaestro market context
Trend signal active
52 weeks +0.6% · Next-week setup negative 41.2%